Literature DB >> 3900120

Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance.

E Fraze, C C Donner, A L Swislocki, Y A Chiou, Y D Chen, G M Reaven.   

Abstract

Plasma glucose, insulin, and FFA concentrations were determined in 15 normal subjects and 15 patients with noninsulin-dependent diabetes mellitus (NIDDM) from 0800 to 1600 h. Breakfast and lunch were consumed at 0800 and 1200 h, respectively, and plasma concentrations were measured at hourly intervals from 0800-1600 h. Plasma glucose concentrations between 0800 and 1600 h were significantly elevated in patients with NIDDM, and the higher the fasting glucose level, the greater the postprandial hyperglycemia. Hyperglycemia in patients with NIDDM was associated with plasma insulin levels that were significantly higher (P less than 0.001) than those in normal subjects, and substantial hyperinsulinemia occurred between 0800 and 1600 h in patients with mild NIDDM (fasting plasma glucose concentrations, less than 140 mg/dl). Both fasting and postprandial FFA levels were also increased in patients with NIDDM (P less than 0.001), and the greater the plasma glucose response, the higher the FFA response (r = 0.70; P less than 0.001). However, there was no significant correlation between plasma insulin and FFA concentrations. More specifically, hyperinsulinemic patients with mild diabetes (fasting plasma glucose, less than 140 mg/dl) maintained normal ambient FFA levels, while FFA concentrations were significantly elevated in patients with severe NIDDM (fasting plasma glucose, greater than 250 mg/dl), with insulin concentrations comparable to those in normal subjects. These results demonstrate that patients with NIDDM are not capable of maintaining normal plasma FFA concentrations. This defect in FFA metabolism is proportionate to the magnitude of hyperglycemia and occurs despite the presence of elevated levels of plasma insulin. These results are consistent with the view that insulin resistance in NIDDM also involves the ability of insulin to regulate FFA metabolism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900120     DOI: 10.1210/jcem-61-5-807

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  50 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 2.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  The Divergent Roles of Dietary Saturated and Monounsaturated Fatty Acids on Nerve Function in Murine Models of Obesity.

Authors:  Amy E Rumora; Giovanni LoGrasso; John M Hayes; Faye E Mendelson; Maegan A Tabbey; Julia A Haidar; Stephen I Lentz; Eva L Feldman
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes.

Authors:  Partha Chakrabarti; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2009-03-17       Impact factor: 5.157

6.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Authors:  L C Groop; R C Bonadonna; S DelPrato; K Ratheiser; K Zyck; E Ferrannini; R A DeFronzo
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 7.  Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome.

Authors:  J Schrezenmeir
Journal:  Experientia       Date:  1996-05-15

8.  Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  C Saloranta; A Franssila-Kallunki; A Ekstrand; M R Taskinen; L Groop
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

Review 9.  The outliers become a stampede as immunometabolism reaches a tipping point.

Authors:  Barbara S Nikolajczyk; Madhumita Jagannathan-Bogdan; Gerald V Denis
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

10.  Quantitative analysis of the magnitude and time delay of cyclic variation of myocardial backscatter from asymptomatic type 2 diabetes mellitus subjects.

Authors:  Allyson A Gibson; Jean E Schaffer; Linda R Peterson; Kyle R Bilhorn; Karla M Robert; Troy A Haider; Marsha S Farmer; Mark R Holland; James G Miller
Journal:  Ultrasound Med Biol       Date:  2009-07-17       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.